JPRN-UMIN000000669CompletedPhase 1
eoadjuvant immunochemotherapy using intratumoral injection of dendritic cells for thoracic esophageal cancers - Neoadjuvant immunochemotherapy using intratumoral injection of dendritic cells for thoracic esophageal cancers
Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University0 sites10 target enrollmentStarted: September 1, 2007Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 1
- Status
- Completed
- Sponsor
- Enrollment
- 10
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to 80years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients with serious concomitant disease Patients with autoimmune disease
Investigators
Similar Trials
Completed
Phase 2
Postoperative adjuvant immunochemotherapy of tumor specific peptide vaccine plus CDDP+5FU chemotherapy for esophageal cancer patients with pathological lymph node metastasis who underwent no preoperative treatment- Multicenter Phase II trialesophageal cancerJPRN-UMIN000003556Kinki University Faculty of Medicine60
Active, not recruiting
Phase 1
Early immunotherapy with intravenous immunoglobulin, cyclophosphamide and methylprednisolone in patients with anti-Hu-associated paraneoplastic sensory neuropathy (NESPA).paraneoplastic sensory neuropathy with anti-Hu antibodiesMedDRA version: 20.0Level: PTClassification code: 10072106Term: Paraneoplastic neurological syndrome Class: 100000004852CTIS2023-506942-22-01Assistance Publique Hopitaux De Paris21
Completed
Phase 2
Postoperative adjuvant immunotherapy of tumor specific peptide vaccine for esophageal cancer patients with pathological lymph node metastasis who underwent preoperative therapy followed by surgery- single institute exploratory Phase II trialesophageal cancerJPRN-UMIN000003557Kindai University Faculty of Medicine, Department of Surgery60
Recruiting
Phase 2
eoadjuvant Immune-Chemo-Radiotherapy in operable oEsophageal and gastro-oesophageal junction cancers with Carboplatin Paclitaxel Radiotherapy and Avelumab - a Trial assessing feasibility and preliminary EfficacyOesophageal cancergastro-oesophageal junction cancerCancer - Oesophageal (gullet)ACTRN12619000288123Southern Adelaide Local Health Network Inc52
Not yet recruiting
Phase 1
Gastric cancer immunotherapyIRCT20170208032451N1Mashhad University of Medical Sciences5